# PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL-TASK AREA 2, PCT0050-01: HESC-DERIVED CARDIOMYOCYTE PROGENITOR CE

> **NIH NIH N01** · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · 2021 · $251,745

## Abstract

The Center for Biomedicine and Genetics (CBG) at City of Hope (COH) is a cGMP manufacturing facility dedicated to providing COH researchers and their collaborators support in all aspects of translational research, including expertise in translating laboratory-based procedures for novel and emerging cell and gene therapy technologies to pilot-scale pre-clinical cGLP processes and fully cGMP=compliant manufacturing processes. IN this proposal, they propose to supply human embryonic stem cell (hESC)-derived cardiomayocytes (CM) to PACT investigator, Joseph Wu, MD, PhD (Stanford School of Medicine), in support of his IND-enabling research for his submitted IND.

## Key facts

- **NIH application ID:** 10470435
- **Project number:** 268201600011I-0-759202100001-1
- **Recipient organization:** BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
- **Principal Investigator:** JOSEPH GOLD
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $251,745
- **Award type:** —
- **Project period:** 2020-10-20 → 2021-07-20

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10470435

## Citation

> US National Institutes of Health, RePORTER application 10470435, PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL-TASK AREA 2, PCT0050-01: HESC-DERIVED CARDIOMYOCYTE PROGENITOR CE (268201600011I-0-759202100001-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10470435. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*